State Board of Administration of Florida Retirement System’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,126
Closed -$41K 2311
2022
Q1
$41K Hold
3,126
﹤0.01% 2340
2021
Q4
$55K Hold
3,126
﹤0.01% 2371
2021
Q3
$68K Hold
3,126
﹤0.01% 2380
2021
Q2
$109K Hold
3,126
﹤0.01% 2354
2021
Q1
$308K Hold
3,126
﹤0.01% 2032
2020
Q4
$339K Hold
3,126
﹤0.01% 1958
2020
Q3
$322K Hold
3,126
﹤0.01% 1856
2020
Q2
$653K Buy
3,126
+770
+33% +$136K ﹤0.01% 1501
2020
Q1
$230K Buy
2,356
+381
+19% +$44.4K ﹤0.01% 1850
2019
Q4
$228K Hold
1,975
﹤0.01% 2080
2019
Q3
$108K Hold
1,975
﹤0.01% 2196
2019
Q2
$235K Buy
1,975
+387
+24% +$32K ﹤0.01% 2065
2019
Q1
$83K Hold
1,588
﹤0.01% 2270
2018
Q4
$50K Hold
1,588
﹤0.01% 2305
2018
Q3
$96K Hold
1,588
﹤0.01% 2350
2018
Q2
$84K Buy
+1,588
New +$95.5K ﹤0.01% 2368

Other funds holding ADVM

State Board of Administration of Florida Retirement System's ADVM Position: Q2 2022 in Review

State Board of Administration of Florida Retirement System sold out of Adverum Biotechnologies (ADVM) in Q2 2022, closing a stake of 3,126 shares — an estimated $41K sold.

State Board of Administration of Florida Retirement System first reported a position in ADVM in Q2 2018 and held it in 16 quarters. The position peaked at $653K in Q2 2020. 77 funds tracked by Wall St. Rank hold ADVM as of Q2 2022.

  • State Board of Administration of Florida Retirement System reported no remaining Adverum Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 3,126 Adverum Biotechnologies shares in Q2 2022, an estimated $41K.
  • State Board of Administration of Florida Retirement System first reported a position in Adverum Biotechnologies in Q2 2018 and held it in 16 quarters.
  • State Board of Administration of Florida Retirement System's Adverum Biotechnologies position peaked at $653K in Q2 2020.
  • 77 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2022.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2022, filed 5 Aug 2022.